Predict - a Translational Study to Predict Tumour Response to Neoadjuvant Treatment

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

All adult patients with colorectal cancer presenting within the Sahlgrenska University Hospital or treated at any time at Sahlgrenska University Hospital are eligible and will be asked to participate. We already have biopsies taken at surgery in patients that receive surgery, but this study will include all patients and the biopsies will be taken during endoscopy for diagnosis of the primary tumour. Biopsies will then be taken during follow-up exams prior surgery but after neoadjuvant treatment. Biopsies will also be taken during surgery and in cases where surgery is not necessary biopsies will be taken regularly during follow-up exams. Blood samples and in relevant cases urinary samples and mouth swabs will be taken at all timepoints when biopsies are taken. If it is not possible to take biopsies prior treatment blood samples will still be drawn.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Colorectal cancer

Locations
Other Locations
Sweden
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
RECRUITING
Gothenburg
Contact Information
Primary
Eva Angenete
eva.angenete@vgregion.se
0760514441
Time Frame
Start Date: 2019-02-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 800
Treatments
Patients without neoadjuvant treatment
Patients with short course radiotherapy
Patients with long course chemoradiotherapy
Patients with short course radiotherapy and deferred surgery
Related Therapeutic Areas
Sponsors
Collaborators: Göteborg University
Leads: Sahlgrenska University Hospital

This content was sourced from clinicaltrials.gov